What’s that rash? Put some thought into asking Google for medical help
Dr. Google is often on call for worried patients, but it may not give the best advice.
Powered by WPeMatico
Gabapentinoids unlikely to be directly linked to self-harm risk, study finds
Treatment with gabapentinoids—drugs such as gabapentin and pregabalin—is not directly associated with an increased risk of self-harm, finds a UK study published by The BMJ.
Powered by WPeMatico
‘No-touch’ vein harvesting has meaningful benefits for heart bypass patients, finds study
‘No-touch’ vein harvesting significantly reduces the risk of graft failure up to three years after coronary artery bypass surgery compared with conventionally harvested vein grafts, finds a study from China published by The BMJ.
Powered by WPeMatico
Novel breath test shows promise for diagnosing and monitoring bacterial infections
A new, non-invasive breath test has emerged as a potential breakthrough for rapidly diagnosing bacterial infections and tracking treatment effectiveness.
Powered by WPeMatico
Investigational gene therapy gives children with rare immune disorder a new lease on life
An investigational gene therapy has successfully restored immune function in all nine children treated with the rare and life-threatening immune disorder called severe leukocyte adhesion deficiency-I, or LAD-I, in an international clinical trial co-led by UCLA.
Powered by WPeMatico
NMC Flags 86 Medical Colleges Over Annual Declaration Report Lapses, 20 institutes slapped show cause notices
New Delhi: Cracking the whip on non-compliance, the National Medical Commission (NMC) has named 20 medical colleges that failed to submit their Annual Declaration Reports (ADRs) despite repeated notices and has issued show cause notices to them. The defaulting colleges have now been given a final opportunity to upload the required data by May 12, 2025, along with a penalty of Rs 50,000 per course, inclusive of GST.
While previously the last date to submit the annual declaration was 02.05.2025, the Postgraduate Medical Education Board (PGMEB) of NMC has now extended it till 12.05.2025.
Apart from the defaulting colleges, the Commission also released a list of 66 medical colleges that submitted incomplete Annual Disclosure Reports (ADRs) and asked these colleges to resubmit the same on the Commission’s portal.
“Reference is invited to the Public Notice of even number dated 01.10.2024, 29.10.2024 and 14.11.2024 with regard to uploading of ADRs by the Medical Colleges/Institutes, running PG Medical courses, on National Medical Commission (NMC) Portal as required in the NMC Act, 2019 and various Regulations, issued by NMC in the matter,” NMC PG Board mentioned in the notice dated 29.04.2025.
“It has been observed that despite three (3) Public Notices through the NMC website, twenty (20) colleges/institutes, as per attached list, have failed to upload their data for which a Show Cause Notice has already been served on them. This has been viewed very seriously by the Competent Authority in the NMC,” the PG Board of the Commission further mentioned.
Announcing its decision to extend the deadline for submission and asking the defaulting colleges to submit the same along with the penalty, the PGMEB further mentioned, “However, in order to complete the exercise, the PGME Board hereby extends the last date for submission of Annual Declaration Report on NMC portal from 02.05.2025 to 12.05.2025 by the defaulting colleges together with a penalty of Rs.50,000/- (including GST) per course. The other terms and conditions mentioned in the aforesaid Public Notices shall remain the same.”
NMC also addressed the 66 medical colleges that submitted incomplete data and added, “Further, in addition to these defaulting colleges, ADR forms of some of the streams/colleges could not be uploaded/downloaded properly (AnnexB). Therefore, these colleges are requested to re-load the ADRs.”
Referring to the PG Board’s notice, the Secretary of NMC, Dr. Raghav Langer wrote to the Principal/Dean of all the medical colleges/ medical institutes under NMC and stated, “Reference is invited to letter no. N-P016(20)/2/2024-PGMEB-NMC dated 29th April, 2025 issued by the Post Graduate Medical Education Board (PGMEB) pertaining to extension of last date for submission of Annual Declaration Report (ADR) in respect of PG Medical courses through NMC portal from 02-05-2025 to 12-05-2025 by the defaulting colleges (Annexure-A to the PGMEB notice) together with a penalty of Rs.50,000/- (including GST) per course.”
“Colleges/Streams, wherein ADR forms could not be uploaded/downloaded properly are also requested to re-load the ADRs (Annexure-B to PGMEB notice). All concerned stakeholders are requested to kindly take note of the same for further necessary action,” the Communication dated 30.04.2025 issued by the NMC Secretary further mentioned.
Medical Dialogues had earlier reported Stating that no MBBS seats will be permitted if the medical college does not submit the Annual Declaration within a specific deadline, the Undergraduate Medical Education Board (UGMEB) of the National Medical Commission directed the medical colleges to submit the details along with requisite fee including GST on NMC portal by 30 November 2024.
Consequently, NMC extended the deadline for submission several times and asked the colleges to comply with its directions. However, several colleges failed to comply with NMC’s directions despite multiple notices and on 28.03.2025, the Commission asked the colleges to submit a penalty of Rs 50,000 along with the ADR.
To view the latest NMC notice, click on the link below:
Powered by WPeMatico
Pahalgam attack: Padma doctors condemn terror, pledge medical assistance
New Delhi: The Padma Awardees Doctors Forum, comprising some of India’s most distinguished medical professionals, has strongly condemned the recent heinous terror attack in Pahalgam, which claimed the lives of 26 innocent civilians. The forum has committed to providing comprehensive medical assistance to the victims and their families.
In a heartfelt letter addressed to Prime Minister Narendra Modi, the forum, comprising 82 signatories, expressed deep anguish and outrage over the brutal attack.
“An act of terror that so brutally extinguishes lives is not only a national tragedy but also a profound moral affront,” the letter stated, news agency PTI reported.
The doctors emphasised their unwavering commitment to peace, resilience, and the sanctity of human life, condemning the attack as “a heinous assault on peace, humanity, and the values we collectively uphold.”
Beyond the condemnation, the forum has offered tangible assistance to the victims and their families, pledging comprehensive medical support.
“In our personal and professional capacities, we stand ready to offer medical assistance — including free consultancy and rehabilitation support’ — to those injured in the attack,” the statement added.
Additionally, they have extended this support to grieving families, providing medical guidance or counselling to help them navigate through their challenging times.
The Padma Awardees Doctor Forum, comprising India’s highest civilian awardees for medical contributions, reaffirmed its solidarity with the government’s efforts in ensuring security and justice.
“Our hearts go out to the bereaved families and to all those affected by this senseless act of violence. We remain united in grief and in our enduring commitment to peace, resilience, and the defence of human dignity,” the statement said, reports PTI.
Powered by WPeMatico
Strides Pharma Science Singapore arm secures USFDA nod for nonsteroidal anti-inflammatory drug
Bangalore: Strides Pharma Global Pte. Limited, a step-down wholly owned subsidiary of Strides Pharma Science Limited in Singapore, has received approval from the United States Food & Drug Administration (USFDA) for Celecoxib Capsules, 100 mg, 200 mg, and 400 mg.
The product is bioequivalent and therapeutically equivalent to the reference listed drug (RLD), Celebrex Capsules, 100 mg, 200 mg, and 400 mg, of Upjohn US 2 LLC.
Celecoxib is a selective COX-2 inhibitor used for the management of pain and inflammation associated with
various conditions including osteoarthritis, rheumatoid arthritis, acute pain, and dysmenorrhea. Celecoxib
Capsules, 100 mg, 200 mg, and 400 mg have a combined market size of ~US$ 116 Mn as per IMS.
“The approval of Celecoxib Capsules strengthens Strides’ portfolio in the anti-inflammatory therapeutic segment. This approval complements the company’s existing products in the same therapy area and enhances its ability to serve a broader patient population with effective, affordable treatment options,” Strides stated.
The product will be manufactured at the company’s facility in Puducherry.
Medical Dialogues team had earlier reported that Strides Pharma Global Pte. Limited, Singapore, had received approval for Acetaminophen and Ibuprofen Tablets, 125 mg /250 mg (OTC), from the USFDA.
Read also: Strides Pharma Science arm gets USFDA nod for Acetaminophen and Ibuprofen Tablets
Strides, a global pharmaceutical company headquartered in Bengaluru, India, is listed on the BSE Limited
(532531) and National Stock Exchange of India Limited (STAR). The Company mainly operates in the
regulated markets and has an “in Africa for Africa” strategy and an institutional business to service donorfunded markets. The Company’s global manufacturing sites are located in India (Chennai, Puducherry, and
two locations in Bengaluru), Italy (Milan), Kenya (Nairobi), and the United States (New York).
Read also: Strides Pharma buys four approved ANDAs from Nostrum Labs for over Rs 17 crore
Powered by WPeMatico
NBE Releases DNB PDCET 2025 Scorecards
New Delhi- The National Board of Examinations in Medical Sciences (NBEMS) has released the scorecard of Diplomate of National Board-Post Diploma Centralised Entrance Test (DNB PDCET) 2025 on April 29, 2025. Therefore, to download the scorecard, students who have qualified the DNB-PDCET need to visit the official website of NBE.
The DNB PDCET Scorecard download link 2025 has been activated on NBE’s official website. Meanwhile, candidates need to enter their login credentials on the candidate portal to download the scorecard.
THE DNB PDCET scorecard 2025 is an important document that contains the details and performance of the candidates in the DNB PDCET exam. Details such as roll number, marks obtained, and rank obtained in the entrance exam are included in the scorecard of DNB PDCET 2025. The credentials required to download the DNB PDCET 2024 scorecard are application number and password/and date of birth. Apart from this, the DNB PDCET scorecard is also an essential document to appear in the counselling process.
STEPS TO DOWNLOAD THE DNB-PDCET 2025 SCORECARD
STEP 1- Visit the official website of NBE.
STEP 2- Select the “DNB PDCET” link from the examination tab.
STEP 3- Enter application number and password in the candidate login section.
STEP 4- Search for the DNB PDCET scorecard download link.
STEP 5- Download the DNB PDCET scorecard and take a printout for future reference.
The National Board of Examinations (NBE) was established in 1975 in New Delhi. It is an autonomous entity within the Ministry of Health and Family Welfare, Government of India. NBE conducts a few examinations, such as DNB final (exit) examinations, Fellowship Entrance and Exit examinations, NEET-SS for admission to DM/Mch/DrNB superspecialty medical courses across India, etc.
Powered by WPeMatico
Rs 4,474 crore makeover for SCB Medical College Hospital to meet AIIMS Standard
Bhubaneswar: In a move aimed at revolutionising healthcare and medical education in Odisha, Chief Minister Mohan Charan Majhi has announced that SCB Medical College and Hospital in Cuttack will be upgraded to AIIMS++ standards by June 2026, positioning it as a premier centre of excellence.
The announcement was made following a high-level review meeting at Lok Seva Bhawan on Tuesday, where ongoing redevelopment projects of government medical institutions across the state were assessed.
As per the latest review, the redevelopment of SCB Medical College is in progress with a projected investment of ₹4,474.49 crore and a target completion date of June 2026. Upon completion of the first phase, the hospital’s bed capacity will expand to 3,796, with a vision to transform the institution into a centre of excellence in both healthcare delivery and medical education.
Chief Minister Majhi emphasized the importance of aligning SCB’s infrastructure and services with national benchmarks like AIIMS.
Also Read: Odisha CM announces establishment of health university
According to Sambad English, in addition, the Acharya Harihar Post Graduate Institute of Cancer is also undergoing redevelopment. The first phase of the project involves an investment of ₹895.89 crore. Once the second phase is completed, the hospital’s bed capacity will expand to 1,127.
The state government is also undertaking major redevelopment efforts at several other key medical institutions. According to news reports at VIMSAR in Burla, an investment of ₹1,594 crore will see the bed capacity increase from 1,485 to 2,861. Similarly, MKCG Medical College in Berhampur is undergoing redevelopment at a cost of ₹1,014.13 crore, with bed capacity set to grow from 1,583 to 2,033. In Rourkela, the Government Hospital has been allocated ₹627.16 crore, which will expand its bed count from 437 to 763. Meanwhile, the Capital Hospital in Bhubaneswar is being redeveloped under a ₹595.8 crore plan, boosting its bed strength from 750 to 2,582.
These upgraded institutions will include cutting-edge healthcare infrastructure such as modern academic buildings, hostels, patient and attendant accommodations, residential quarters for staff, auditoriums, sports complexes, and digital facilities. The goal is to ensure equitable access to quality healthcare services and improve medical training standards across the state.
Powered by WPeMatico